{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:46:51Z","timestamp":1772480811500,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-024-00922-x","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T11:01:57Z","timestamp":1722682917000},"page":"141-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MYH9-related disease with a normal platelet count"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-0251","authenticated-orcid":false,"given":"Ryo","family":"Nakatani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-8482","authenticated-orcid":false,"given":"Kenichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3734-4766","authenticated-orcid":false,"given":"Yoko","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sekiko","family":"Taneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuho","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4309-8672","authenticated-orcid":false,"given":"Motoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"issue":"4","key":"922_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1053\/j.ajkd.2009.06.023","volume":"54","author":"N Singh","year":"2009","unstructured":"Singh N, Nainani N, Arora P, et al. CKD in MYH9-related disorders. Am J Kidney Dis. 2009;54(4):732\u201340. https:\/\/doi.org\/10.1053\/j.ajkd.2009.06.023.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"922_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/ckj\/sfy117","volume":"12","author":"N Tabibzadeh","year":"2019","unstructured":"Tabibzadeh N, Fleury D, Labatut D, et al. MYH9-related disorders display heterogeneous kidney involvement and outcome. Clin Kidney J. 2019;12(4):494\u2013502. https:\/\/doi.org\/10.1093\/ckj\/sfy117.","journal-title":"Clin Kidney J"},{"issue":"4","key":"922_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18(4):626\u201333. https:\/\/doi.org\/10.1007\/s10157-013-0856-y.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"922_CR4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood.v97.4.1147","volume":"97","author":"S Kunishima","year":"2001","unstructured":"Kunishima S, Kojima T, Matsushita T, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly\/Sebastian syndrome). Blood. 2001;97(4):1147\u20139. https:\/\/doi.org\/10.1182\/blood.v97.4.1147.","journal-title":"Blood"},{"issue":"1","key":"922_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10157-023-02404-3","volume":"28","author":"Y Shirai","year":"2024","unstructured":"Shirai Y, Miura K, Hamada R, et al. A nationwide survey of MYH9-related disease in Japan. Clin Exp Nephrol. 2024;28(1):40\u20139. https:\/\/doi.org\/10.1007\/s10157-023-02404-3.","journal-title":"Clin Exp Nephrol"},{"key":"922_CR6","doi-asserted-by":"publisher","first-page":"5149762","DOI":"10.1155\/2019\/5149762","volume":"2019","author":"S Teshirogi","year":"2019","unstructured":"Teshirogi S, Muratsu J, Kasahara H, et al. Two cases of the myh9 disorder fechtner syndrome diagnosed from observation of peripheral blood cells before end-stage renal failure. Case Rep Nephrol. 2019;2019:5149762. https:\/\/doi.org\/10.1155\/2019\/5149762.","journal-title":"Case Rep Nephrol"},{"issue":"1","key":"922_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ajcp\/72.1.111","volume":"72","author":"NM Clare","year":"1979","unstructured":"Clare NM, Montiel MM, Lifschitz MD, et al. Alport\u2019s syndrome associated with macrothrombopathic thrombocytopenia. Am J Clin Pathol. 1979;72(1):111\u20137. https:\/\/doi.org\/10.1093\/ajcp\/72.1.111.","journal-title":"Am J Clin Pathol."},{"issue":"12","key":"922_CR8","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1093\/ndt\/gft350","volume":"28","author":"K Miura","year":"2013","unstructured":"Miura K, Kurihara H, Horita S, et al. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2013;28(12):2993\u20133003. https:\/\/doi.org\/10.1093\/ndt\/gft350.","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"922_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ki.2010.82","volume":"78","author":"JB Kopp","year":"2010","unstructured":"Kopp JB. Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism? Kidney Int. 2010;78(2):130\u20133. https:\/\/doi.org\/10.1038\/ki.2010.82.","journal-title":"Kidney Int"},{"issue":"8","key":"922_CR10","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/ndt\/gfn277","volume":"23","author":"A Pecci","year":"2008","unstructured":"Pecci A, Granata A, Fiore CE, et al. Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome). Nephrol Dial Transplant. 2008;23(8):2690\u20132. https:\/\/doi.org\/10.1093\/ndt\/gfn277.","journal-title":"Nephrol Dial Transplant."},{"issue":"20","key":"922_CR11","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.2169\/internalmedicine.2997-19","volume":"58","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Miki S, Saita H, et al. Renin-angiotensin system blockade therapy for early renal involvement in MYH9-related disease with an E1841K mutation. Intern Med. 2019;58(20):2983\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.2997-19.","journal-title":"Intern Med."},{"issue":"1","key":"922_CR12","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.1038\/s41598-019-44194-3","volume":"9","author":"JS Kang","year":"2019","unstructured":"Kang JS, Lee SJ, Lee JH, et al. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Sci Rep. 2019;9(1):7679. https:\/\/doi.org\/10.1038\/s41598-019-44194-3.","journal-title":"Sci Rep."},{"issue":"4","key":"922_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00467-010-1735-3","volume":"26","author":"KH Han","year":"2011","unstructured":"Han KH, Lee H, Kang HG, et al. Renal manifestations of patients with MYH9-related disorders. Pediatr Nephrol. 2011;26(4):549\u201355. https:\/\/doi.org\/10.1007\/s00467-010-1735-3.","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"922_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/nep.13253","volume":"24","author":"J Hashimoto","year":"2019","unstructured":"Hashimoto J, Hamasaki Y, Takahashi Y, et al. Management of patients with severe Epstein syndrome: review of four patients who received living-donor renal transplantation. Nephrology (Carlton). 2019;24(4):450\u20135. https:\/\/doi.org\/10.1111\/nep.13253.","journal-title":"Nephrology (Carlton)."}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00922-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T03:23:41Z","timestamp":1743650621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00922-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00922-x","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,3]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards and the national and institutional standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient and his guardian signed the consent form and agreed to publish this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}